PLoS ONE (Jan 2013)

MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity.

  • Ying He,
  • Guili Lian,
  • Shuyong Lin,
  • Zhiyun Ye,
  • Qinxi Li

DOI
https://doi.org/10.1371/journal.pone.0067529
Journal volume & issue
Vol. 8, no. 6
p. e67529

Abstract

Read online

MDM2 plays a crucial role in negatively regulating the functions of tumor suppressor p53. Here we show that MDM2 can inhibit Axin-stimulated p53-dependent apoptosis by suppressing p53 phosphorylation at Ser 46 and apoptosis-related p53 transactivational activity. Interestingly, the ubiquitin E3 ligase activity of MDM2 is not required for this inhibitory effect. Mechanically, either wildtype MDM2 or its E3-dead mutant, disrupts the Axin-based HIPK2/p53 complex formation by blocking the binding of p53 and HIPK2 to Axin. MDM2Δp53, a deletion mutant that lacks p53 binding domain fails to exert the inhibitory effect, demonstrating that the interaction of MDM2 and p53, but not its E3 ligase activity toward p53 plays key role in suppressing Axin-stimulated p53 activation. Our results thus have revealed a novel aspect of the mechanism by which MDM2 regulates p53 activities.